These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 32463461

  • 1. β-elemene suppresses Warburg effect in NCI-H1650 non-small-cell lung cancer cells by regulating the miR-301a-3p/AMPKα axis.
    Li L, Zhao D, Cheng G, Li Q, Chu Y, Chu H, Ding Y, Li C.
    Biosci Rep; 2020 Jun 26; 40(6):. PubMed ID: 32463461
    [Abstract] [Full Text] [Related]

  • 2. β-elemene inhibited expression of DNA methyltransferase 1 through activation of ERK1/2 and AMPKα signalling pathways in human lung cancer cells: the role of Sp1.
    Zhao S, Wu J, Zheng F, Tang Q, Yang L, Li L, Wu W, Hann SS.
    J Cell Mol Med; 2015 Mar 26; 19(3):630-41. PubMed ID: 25598321
    [Abstract] [Full Text] [Related]

  • 3. Hsa-miR-301a-3p inhibited the killing effect of natural killer cells on non-small cell lung cancer cells by regulating RUNX3.
    Zhang J, Yang Y, Wei Y, Li L, Wang X, Ye Z.
    Cancer Biomark; 2023 Mar 26; 37(4):249-259. PubMed ID: 37302028
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.
    Zhao X, Lu C, Chu W, Zhang B, Zhen Q, Wang R, Zhang Y, Li Z, Lv B, Li H, Liu J.
    Tumour Biol; 2017 May 26; 39(5):1010428317706215. PubMed ID: 28488541
    [Abstract] [Full Text] [Related]

  • 6. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis.
    Huang Q, Xing S, Peng A, Yu Z.
    Biosci Rep; 2020 Jan 31; 40(1):. PubMed ID: 31894841
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of miR-33b promotes non-small cell lung cancer cell growth through reprogramming glucose metabolism miR-33b regulates non-small cell lung cancer cell growth.
    Zhai S, Zhao L, Lin T, Wang W.
    J Cell Biochem; 2019 Apr 31; 120(4):6651-6660. PubMed ID: 30368888
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. β-elemene regulates endoplasmic reticulum stress to induce the apoptosis of NSCLC cells through PERK/IRE1α/ATF6 pathway.
    Liu Y, Jiang ZY, Zhou YL, Qiu HH, Wang G, Luo Y, Liu JB, Liu XW, Bu WQ, Song J, Cui L, Jia XB, Feng L.
    Biomed Pharmacother; 2017 Sep 31; 93():490-497. PubMed ID: 28672279
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Knockdown of lncRNA MIR503HG suppresses proliferation and promotes apoptosis of non-small cell lung cancer cells by regulating miR-489-3p and miR-625-5p.
    Dao R, Wudu M, Hui L, Jiang J, Xu Y, Ren H, Qiu X.
    Pathol Res Pract; 2020 Mar 31; 216(3):152823. PubMed ID: 31983569
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
    Weng Q, Chen M, Yang W, Li J, Fan K, Xu M, Weng W, Lv X, Fang S, Zheng L, Song J, Zhao Z, Fan X, Ji J.
    FASEB J; 2020 Apr 31; 34(4):5420-5434. PubMed ID: 32080912
    [Abstract] [Full Text] [Related]

  • 17. Thyroid hormone enhances efficacy of cisplatin in lung cancer patients via down-regulating GLUT1 expression and reversing the Warburg effect.
    Fan C, Ren Y, Zhang W, Wen J, Zhang W, Lin S, Bai Y, Zheng T, Abay B, Li M, Fan L.
    Mitochondrion; 2024 Sep 31; 78():101919. PubMed ID: 38876298
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4.
    Hu B, Zhang H, Wang Z, Zhang F, Wei H, Li L.
    Cancer Biol Ther; 2017 Dec 02; 18(12):974-983. PubMed ID: 29020498
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.